| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/1998 | CA2267646A1 Platelet secretory transport protein |
| 04/16/1998 | CA2267637A1 Hypertension markers |
| 04/16/1998 | CA2267223A1 Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans |
| 04/16/1998 | CA2267187A1 Method for preparing compositions for transferring nucleic acids |
| 04/16/1998 | CA2267139A1 Methods and means for selecting peptides and proteins having specific affinity for a target |
| 04/16/1998 | CA2267128A1 Reagents and methods useful for detecting diseases of the prostate |
| 04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | CA2266466A1 Mammary gland-specific promoters |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | CA2255939A1 Herpes simplex virus strains |
| 04/16/1998 | CA2248222A1 Dna encoding galanin galr3 receptors and uses thereof |
| 04/16/1998 | CA2240018A1 Method for detecting nonsense mutations and frameshift mutations |
| 04/15/1998 | EP0835940A1 Method for measurement of inhibition of nitrification activity by ammonia-oxidizing bacteria |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835938A2 Topoisomerase I |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835935A1 Thermostable DNA Polymerase from Anaerocellum thermophilum |
| 04/15/1998 | EP0835934A2 Muteins of streptavidin |
| 04/15/1998 | EP0835933A2 A G-protein coupled receptor, HLTEX11 |
| 04/15/1998 | EP0835932A1 Non- glycosylated FGF-4 and compositions containing the same |
| 04/15/1998 | EP0835928A1 Helicobacter pylori live vaccine |
| 04/15/1998 | EP0835663A2 Combined vaccines comprising Hepatitis B surface antigen and other antigens |
| 04/15/1998 | EP0835661A2 Human interferon-Beta2A for use as a medicament |
| 04/15/1998 | EP0835447A1 Novel peptides and compositions which modulate apoptosis |
| 04/15/1998 | EP0835323A1 Modified proteins and methods of their production |
| 04/15/1998 | EP0835321A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 04/15/1998 | EP0835320A1 Improved retroviral vectors, especially suitable for gene therapy |
| 04/15/1998 | EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 04/15/1998 | EP0835318A2 Vaccines against hepatitis c |
| 04/15/1998 | EP0835317A1 Recombinant human prostate specific antigen and uses thereof |
| 04/15/1998 | EP0835316A1 PHENYLACETYL-CoA LIGASE FROM PENICILLIUM CHRYSOGENUM |
| 04/15/1998 | EP0835315A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/15/1998 | EP0835314A1 Immunogenic detoxified mutant of cholera toxins |
| 04/15/1998 | EP0835313A1 Omp26 antigen from haemophilus influenzae |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835311A2 Cotton fiber transcriptional factors |
| 04/15/1998 | EP0835310A2 Regulatory elements conferring tapetum specificity |
| 04/15/1998 | EP0835309A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 04/15/1998 | EP0835308A1 Bax omega protein and methods |
| 04/15/1998 | EP0835307A2 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835305A1 Cytokine that induces apoptosis |
| 04/15/1998 | EP0835301A1 Human beta 2 integrin alpha subunit |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835262A1 Method for the treatment of corticosteroid induced osteopenia |
| 04/15/1998 | EP0835261A1 Ion channel |
| 04/15/1998 | EP0835238A1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 04/15/1998 | EP0835137A1 Encapsulated cells producing viral particles |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0835133A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 04/15/1998 | EP0835132A1 Novel recombinant temperature sensitive mutants of influenza |
| 04/15/1998 | EP0835131A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86 |
| 04/15/1998 | EP0835122A1 Latent transcripts and promoters of cytomegalovirus |
| 04/15/1998 | EP0835099A1 A method of transfection of cells using liposomally encapsulated nucleic acids |
| 04/15/1998 | EP0804065A4 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 04/15/1998 | EP0702728B1 Magnetic cycle reaction |
| 04/15/1998 | EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 04/15/1998 | EP0650367A4 Blocking intercellular interactions with cd43 chimeric molecules. |
| 04/15/1998 | EP0640130B1 Chimeric multivalent protein analogues and methods of use thereof |
| 04/15/1998 | EP0460052B1 Il-1 biological activity inhibitors |
| 04/15/1998 | CN1179181A GnRH-leukotoxin chimeras |
| 04/15/1998 | CN1179180A RAGE tumer rejection antigens |
| 04/15/1998 | CN1179179A Recombinant human immunodeficiency virus-producing cell |
| 04/15/1998 | CN1179178A Host cell expressing reduced levels of metalloprotease and methods using host cell in protein production |
| 04/15/1998 | CN1179163A Gclq receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1178835A Hear resisting basic phosphatase and its expression |
| 04/15/1998 | CN1178834A Biological synthetic gene II of boitin |
| 04/15/1998 | CA2218456A1 Purified stat proteins and methods of purifying thereof |
| 04/14/1998 | US5739409 Endogenously sweetened transgenic plant products |
| 04/14/1998 | US5739407 Genetic engineering dna encodes a polypeptide |
| 04/14/1998 | US5739311 Enzymatic synthesis of phosphorothioate oligonucleotides using restriction endonucleases |
| 04/14/1998 | US5739310 Use of ribosomal rna as a vehicle for delivering heterologous sequences for gene therapy |
| 04/14/1998 | US5739309 Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectious disease pathogens |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739307 Cell growth factors |
| 04/14/1998 | US5739306 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
| 04/14/1998 | US5739291 Glutamate receptor antibodies |
| 04/14/1998 | US5739289 Produced by specified hybridoma |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739281 Subjecting proteins to a time sequence of multiple denaturing-renaturing cycles |
| 04/14/1998 | US5739271 Drug delivery of oligonucleotides, nucleic acids, peptides, images, and proteins |
| 04/14/1998 | US5739119 Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739106 Appetite regulating compositions |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | US5739101 Administering an anticoagulants |
| 04/14/1998 | US5739082 Method of improving the yield of herbicide-resistant crop plants |
| 04/14/1998 | US5739040 Determining a sequence of bases for a nucleic acid with high speed and accuracy by measuring differences in nucleotide fluorescence wavelengths and lifetimes |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739029 Vectors for expression of G protein coupled receptors in yeast |
| 04/14/1998 | US5739027 MTS1E1β gene |
| 04/14/1998 | US5739026 DNA expression systems based on alphaviruses |
| 04/14/1998 | US5739018 Inducible expression of envelope protein accomplished by operably linking an envelope protein-encoding nucleotide sequence to an inducible promoter |
| 04/14/1998 | US5739012 Stable activator from genetically engineered cells |
| 04/14/1998 | US5739011 DNA for the production of multimeric hemoglobins |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |